logo


You're contacting media contact of this press release

Title: Ethiopia Food and Drug Authority EFDA and Medical Value Chain MVC Bahrain Launch Blockchain-Powered Track and Trace Partnership to Strengthen Pharmaceutical Supply Chain and Safeguard Public Health

Bahrain, 22nd Nov 2024 - The Ethiopia Food and Drug Authority (EFDA) and Medical Value Chain (MVC) are pleased to announce a transformative partnership to implement a cutting-edge blockchain-enabled pharmaceutical track-and-trace system across Ethiopia. This initiative marks a significant leap forward in combating counterfeit medicines and ensuring the safety, authenticity, and reliability of the pharmaceutical supply chain throughout the country.As part of the agreement, MVC—a global innovator in blockchain-based supply chain tracking technology—will work closely with EFDA to establish a secure, end-to-end digital platform for monitoring pharmaceuticals. The track-and-trace solution, powered by MVC's unique, patent-pending dual blockchain technology, will monitor medicines at every stage of the supply chain, from production to patient, ensuring that only genuine, safe products reach Ethiopian citizens. This technology, also utilized in MVC’s SmartPass system, provides a robust layer of verification and transparency unmatched by other solutions.Key Benefits of the EFDA and MVC Track-and-Trace System:Enhanced Public Safety: By preventing counterfeit medicines from infiltrating the market, this system will protect Ethiopian consumers and bolster trust in the healthcare sector.Real-Time Monitoring: The platform’s real-time tracking capabilities empower regulatory authorities to closely monitor each point in the supply chain, detecting any signs of tampering or diversion instantly.Increased Transparency and Accountability: The system provides full visibility to manufacturers, distributors, pharmacies, and regulators, reinforcing safety and quality standards across the board.Global Compliance Standards: Designed to align with GS1 and best practices in pharmaceutical regulati...


This press release is issued by King Newswire

Email Information